Analogic (Nasdaq: ALOG) reported earnings on March 6. Here are the numbers you need to know.

The 10-second takeaway
For the quarter ended Jan. 31 (Q2), Analogic met expectations on revenue and crushed expectations on earnings per share.

Compared to the prior-year quarter, revenue increased and GAAP earnings per share increased significantly.

Margins improved across the board.

Revenue details
Analogic booked revenue of $126.4 million. The four analysts polled by S&P Capital IQ expected net sales of $127.0 million on the same basis. GAAP reported sales were 7.8% higher than the prior-year quarter's $117.3 million.

Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.

EPS details
Non-GAAP EPS came in at $0.84. The three earnings estimates compiled by S&P Capital IQ forecast $0.59 per share on the same basis. GAAP EPS of $1.59 for Q2 were 279% higher than the prior-year quarter's $0.42 per share.

Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.

Margin details
For the quarter, gross margin was 37.1%, 230 basis points better than the prior-year quarter. Operating margin was 6.2%, 200 basis points better than the prior-year quarter. Net margin was 15.5%, 1,100 basis points better than the prior-year quarter.

Looking ahead
Next quarter's average estimate for revenue is $128.4 million. On the bottom line, the average EPS estimate is $0.64.

Next year's average estimate for revenue is $510.2 million. The average EPS estimate is $2.41.

Investor sentiment
The stock has a two-star rating (out of five) at Motley Fool CAPS, with 46 members out of 56 rating the stock outperform, and 10 members rating it underperform. Among 13 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 11 give Analogic a green thumbs-up, and two give it a red thumbs-down.

Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Analogic is outperform, with an average price target of $62.25.

The healthcare investing landscape is littered with also-rans and a few major winners. Is Analogic the right stock for you? Read "Discover the Next Rule-Breaking Multibagger" to learn about a company David Gardner believes will be a phenomenal success over the next few years. Click here for instant access to this free report.